Guilin Sanjin Pharmaceutical Co Ltd (002275) — Free Cash Flow Generation Index
Guilin Sanjin Pharmaceutical Co Ltd (002275) has a Free Cash Flow Generation Index of -0.06x as of September 2025. Free cash flow of CN¥-6.63 Million represents 0% of operating cash flow (CN¥117.62 Million). Explore Guilin Sanjin Pharmaceutical Co Ltd (002275) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Guilin Sanjin Pharmaceutical Co Ltd Free Cash Flow Generation Index (2006–2024)
Historical FCF Generation Index trend for Guilin Sanjin Pharmaceutical Co Ltd across 19 annual periods. For the full cash flow conversion analysis, see Guilin Sanjin Pharmaceutical Co Ltd (002275) cash conversion ratio.
Annual Free Cash Flow Generation for Guilin Sanjin Pharmaceutical Co Ltd (2006–2024)
Year-by-year Free Cash Flow Generation Index for Guilin Sanjin Pharmaceutical Co Ltd. Check cash flow reinvestment rate of Guilin Sanjin Pharmaceutical Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.86x | CN¥506.16 Million | CN¥588.33 Million | CN¥82.18 Million | ▼ -0.1% |
| 2023 | 0.86x | CN¥472.85 Million | CN¥549.25 Million | CN¥76.40 Million | ▼ -2.4% |
| 2022 | 0.88x | CN¥466.40 Million | CN¥528.67 Million | CN¥62.27 Million | ▲ +36.0% |
| 2021 | 0.65x | CN¥266.15 Million | CN¥410.24 Million | CN¥144.09 Million | ▼ -1.2% |
| 2020 | 0.66x | CN¥392.52 Million | CN¥597.99 Million | CN¥205.47 Million | ▲ +26.9% |
| 2019 | 0.52x | CN¥242.14 Million | CN¥468.29 Million | CN¥226.14 Million | ▼ -38.2% |
| 2018 | 0.84x | CN¥461.76 Million | CN¥551.73 Million | CN¥89.96 Million | ▼ -0.5% |
| 2017 | 0.84x | CN¥326.29 Million | CN¥387.82 Million | CN¥61.53 Million | ▼ -4.2% |
| 2016 | 0.88x | CN¥471.49 Million | CN¥536.85 Million | CN¥65.36 Million | ▲ +28.0% |
| 2015 | 0.69x | CN¥273.48 Million | CN¥398.50 Million | CN¥125.02 Million | ▲ +46.9% |
| 2014 | 0.47x | CN¥185.25 Million | CN¥396.53 Million | CN¥211.28 Million | ▲ +11069.8% |
| 2013 | 0.00x | CN¥1.31 Million | CN¥314.16 Million | CN¥312.85 Million | ▼ -98.7% |
| 2012 | 0.32x | CN¥96.96 Million | CN¥302.59 Million | CN¥205.63 Million | ▼ -49.0% |
| 2011 | 0.63x | CN¥214.30 Million | CN¥341.05 Million | CN¥126.75 Million | ▼ -4.1% |
| 2010 | 0.66x | CN¥187.05 Million | CN¥285.49 Million | CN¥98.44 Million | ▼ -22.9% |
| 2009 | 0.85x | CN¥308.61 Million | CN¥363.29 Million | CN¥54.68 Million | ▲ +6.5% |
| 2008 | 0.80x | CN¥152.33 Million | CN¥190.97 Million | CN¥38.64 Million | ▼ -10.7% |
| 2007 | 0.89x | CN¥146.80 Million | CN¥164.39 Million | CN¥17.59 Million | ▲ +3.1% |
| 2006 | 0.87x | CN¥188.51 Million | CN¥217.67 Million | CN¥29.16 Million | — |